UiPath price target raised to $19 from $12 at UBS
Upside remains plausible; UBS positive stance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside remains plausible; UBS positive stance.
What happened, with direct paths to the underlying reporting
UBS increases target to $19; current price $18.15.
Target: $19
Posted price: $18.15
Analyst firm: UBS
Analyst: Radi Sultan
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.